Aceragen, Inc.
Aceragen, Inc., a prominent biotechnology firm headquartered in the United States, is dedicated to advancing innovative therapies for rare diseases. Founded in 2018, the company has quickly established itself in the biopharmaceutical industry, focusing on the development of transformative treatments that address unmet medical needs.
With a strong operational presence across key regions in the US, Aceragen is committed to harnessing cutting-edge science to create unique products that enhance patient outcomes. Their core offerings include novel therapeutics designed to target specific genetic disorders, setting them apart in a competitive market.
Recognised for its rapid growth and commitment to research excellence, Aceragen continues to make significant strides in the biotechnology landscape, positioning itself as a leader in the quest for effective solutions for rare diseases.
-20 vs industry average
Aceragen, Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Aceragen, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Aceragen, Inc. yet.
Aceragen, Inc.'s reported carbon emissions
Aceragen, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Aceragen may still be in the early stages of developing a comprehensive climate strategy.
In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific commitments or data, it is challenging to assess Aceragen's position relative to its peers in terms of carbon emissions and climate action.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Aceragen, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Aceragen, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Aceragen, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project